Press
Press
Malmö, Sweden – Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, is pleased to announce that a second payer has agreed to provide...
Malmö, Sweden – July 8, 2025 – Acarix, a global pioneer in AI-driven and acoustics-based cardiac diagnostics, is proud to announce its first order...
2025-06-26 09:40
Acarix Applauds New Peer-Reviewed Study Demonstrating Cost-Effectiveness of the CADScor® System in U.S. Emergency Departments
Malmö, Sweden - Acarix, a leader in non-invasive cardiac diagnostics, is pleased to announce the publication of a new peer-reviewed study in PharmacoEconomics...
2025-06-16 10:05
Acarix Achieves First Fixed U.S. Reimbursement Milestone for CADScor at $300.00 USD
Malmö, Sweden - Acarix a global leader in AI and acoustics-based cardiac diagnostics, is pleased to announce that the first payor has agreed to provide...
2025-05-19 15:19
CEO purchases shares in Acarix
Acarix, a leader in AI-driven and acoustics-based cardiac diagnostics, has announced that its President and CEO, Aamir Mahmood, has increased his investment...
2025-05-13 16:19
Kommuniké från årsstämma i Acarix AB
Årsstämman 2025 i Acarix AB ("Acarix" eller "Bolaget") hölls idag den 13 maj 2025 varvid aktieägarna fattade följande beslut.
2025-05-13 16:19
Announcement from the annual general meeting in Acarix AB
The annual general meeting 2025 (the "AGM") of Acarix AB ("Acarix" or the "Company") was held today on 13 May 2025 and the following resolutions were passed...
2025-05-12 12:00
Acarix confirms timing of Q1 webcast presentation
The pre-recorded webcast presentation featuring CEO Aamir Mahmood, along with the PDF version of the presentation, will be available on our website today...
2025-05-12 08:00
Acarix Publishes Interim Report, January – March 2025
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today announced its interim financial results for the first quarter of 2025. The...
2025-05-05 16:38
Invitation to presentation of Acarix´s first quarter 2025 report
Acarix invites investors, analysts, and media representatives to join a recorded webcast presentation of the first quarter report for 2025, scheduled for...
2025-04-15 15:00
Acarix AB’s Annual Report 2024
Acarix, a global leader in AI and advanced acoustic-based cardiac diagnostics, today announces that the Annual Report for 2024 is available as a pdf on...
2025-04-15 15:00
Acarix AB’s Årsredovisning 2024
Acarix, ledande inom avancerad akustikbaserad hjärtdiagnostik, meddelar idag att årsredovisning för 2024 finns tillgänglig som pdf på bolagets hemsida...
2025-04-10 15:50
NOTICE OF ANNUAL GENERAL MEETING IN Acarix AB
The shareholders in Acarix AB (publ) corp. reg. no 559009-0667 (the “Company”) are hereby convened to an annual general meeting on Tuesday 13 May 2025...
2025-04-10 15:50
KALLELSE TILL ÅRSSTÄMMA I Acarix AB
Aktieägarna i Acarix AB, org.nr 559009-0667 (”Bolaget”) kallas härmed till årsstämma tisdagen den 13 maj 2025 kl. 14.00 på Cecil Coworking, Norrlandsgatan...
2025-03-17 14:57
CEO purchases shares in Acarix
Acarix, a leader in AI-driven and acoustics-based cardiac diagnostics, has announced that its President and CEO, Aamir Mahmood, has increased his investment...
Malmö, Sweden — Acarix, a global leader in AI and acoustics-based cardiac diagnostics, has been awarded the 2025 Digital Innovation Award with the honorable...
2025-02-17 09:36
CEO purchases shares in Acarix
Acarix, a leader in AI-driven and acoustics-based cardiac diagnostics, has announced that its President and CEO, Aamir Mahmood, has increased his investment...
2025-02-13 08:00
Acarix AB (publ) Publishes Year-End Report 2024 - Sales and revenue for the CADScor System and patches are surging amid ongoing U.S. expansion efforts
Malmö — Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its 2024 year-end financial results. “The company continues...
2025-02-05 09:35
Acarix Partners with Geo-Med to Extend the Availability of the CADScor System for Veterans
OKLAHOMA CITY — Acarix, a pioneer in the development of groundbreaking acoustic-based cardiac diagnostic solutions, is proud to announce a new strategic...
2025-01-30 10:05
Invitation to presentation of Acarix´s fourth quarter 2024 report
Acarix invites investors, analysts, and media representatives to join a recorded webcast presentation of the fourth quarter report for 2024, scheduled...
2024-11-11 15:16
Nomination Committee for Acarix Annual General Meeting 2025
A Nomination Committee consisting of shareholder representatives and the Chairman of the Board of Directors has been established for Acarix AB (publ) in...
2024-11-07 08:00
Acarix AB (publ) publicerar tredje kvartalet 2024
Acarix, ledande inom akustisk- och algoritmbaserad hjärtdiagnostik, redovisade idag sina finansiella resultat för det tredje kvartalet 2024. Bolaget...
2024-11-07 08:00
Acarix Publishes Third Quarter 2024 Report
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its financial results for the third quarter of 2024. The company has...
2024-11-06 17:55
Invitation to presentation of Acarix´s third quarter 2024 report
Correction: Correction refers to the publication of the Q3 presentation occurring after the release of the financial report.
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, is pleased to announce placement of four (4) CADScor systems and sale of 10 boxes...
2024-11-05 09:15
Invitation to presentation of Acarix´s third quarter 2024 report
Acarix invites investors, analysts, and media to a webcast presentation of the third quarter report for 2024 on November 7, 15:00 CET. The report will...
2024-11-04 08:30
Acarix Expands U.S. Reimbursement Coverage for CADScor System for use in Emergency and Outpatient Settings
Malmö, Sweden — Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, announced today that the U.S. Centers for Medicare & Medicaid...
2024-10-14 10:33
Acarix Secures Expansion Order from Existing CADScor System Customer
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, is pleased to announce that a current customer has placed an order for use of additional four...
2024-10-08 09:45
Multi-Location Customer Places Order of the Acarix CADScor System with Goal to Scale Usage
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, is pleased to announce the sale of 9 CADScor Systems and 500 single-use patches to...
Acarix AB ("Acarix" or the "Company") today announces that the Board of Directors has resolved on a directed issue to the guarantors of the warrant of...
About Acarix
Acarix is a Swedish medical device company that innovates solutions for rapid AI-based Coronary Artery Disease (CAD) rule-out.
The CE-mark approved and FDA De Novo cleared Acarix CADScor®System is for patients experiencing stable chest pain with suspected CAD and is designed to help reduce millions of unnecessary and costly diagnostic procedures.2 CADScor®System calculates a patient-specific CAD-score non-invasively in 10 minutes with at least 96% confidence (Negative Predictive Value).¹
Acarix is listed on the Nasdaq First North Premier Growth Market (ticker: ACARIX).
- User manual US-FDA v.12.Y, prevalence 10,7%
- Shaw LJ, Marwick TH, Zoghbi WA, Hundley WG, Kramer CM, Achenbach S, Dilsizian V, Kern MJ, Chandrashekhar Y, Narula J. Why all the focus on cardiac imaging? JACC Cardiovasc Imaging. 2010 Jul;3(7):789-94. doi: 10.1016/j.jcmg.2010.05.004. PMID: 20633864.